QECCSCJSJOOMIO-UHFFFAOYSA-N
C31H34ClF3N8O3 — CID 155098312
Data last refreshed: (MolForge compound catalog, from PubChem)
About QECCSCJSJOOMIO-UHFFFAOYSA-N
QECCSCJSJOOMIO-UHFFFAOYSA-N (PubChem CID 155098312) has the molecular formula C31H34ClF3N8O3 and a molecular weight of 659.11 g/mol. Its IUPAC name is N-[3-chloro-4-[[3-(piperidine-4-carbonyl)-3-azabicyclo[3.1.0]hexan-6-yl]carbamoyl]phenyl]-5-[1-(cyclopropylmethyl)-3-(trifluoromethyl)pyrazol-4-yl]-1-methylimidazole-2-carboxamide.
Molecular Properties
| Compound Name | QECCSCJSJOOMIO-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 155098312 |
| Molecular Formula | C31H34ClF3N8O3 |
| Molecular Weight | 659.11 g/mol |
| Exact Mass | 658.24 |
| IUPAC Name | N-[3-chloro-4-[[3-(piperidine-4-carbonyl)-3-azabicyclo[3.1.0]hexan-6-yl]carbamoyl]phenyl]-5-[1-(cyclopropylmethyl)-3-(trifluoromethyl)pyrazol-4-yl]-1-methylimidazole-2-carboxamide |
| SMILES | Cn1c(-c2cn(CC3CC3)nc2C(F)(F)F)cnc1C(=O)Nc1ccc(C(=O)NC2C3CN(C(=O)C4CCNCC4)CC32)c(Cl)c1 |
| InChI | InChI=1S/C31H34ClF3N8O3/c1-41-24(22-15-43(12-16-2-3-16)40-26(22)31(33,34)35)11-37-27(41)29(45)38-18-4-5-19(23(32)10-18)28(44)39-25-20-13-42(14-21(20)25)30(46)17-6-8-36-9-7-17/h4-5,10-11,15-17,20-21,25,36H,2-3,6-9,12-14H2,1H3,(H,38,45)(H,39,44) |
| InChIKey | QECCSCJSJOOMIO-UHFFFAOYSA-N |
| XLogP | 3.80 |
| TPSA | 126.18 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 659.11 |
| LogP ≤ 5 | 3.80 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155098312 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.